CDSN
Corneodesmosin
Also known as: CDSN_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q15517
- Gene
- CDSN
- Canonical length
- 529 aa
- Protein class
- Human disease related genes, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for CDSN in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>Q15517|CDSN
1 MGSSRAPWMG RVGGHGMMAL LLAGLLLPGT LAKSIGTFSD PCKDPTRITS PNDPCLTGKG
61 DSSGFSSYSG SSSSGSSISS ARSSGGGSSG SSSGSSIAQG GSAGSFKPGT GYSQVSYSSG
121 SGSSLQGASG SSQLGSSSSH SGNSGSHSGS SSSHSSSSSS FQFSSSSFQV GNGSALPTND
181 NSYRGILNPS QPGQSSSSSQ TFGVSSSGQS VSSNQRPCSS DIPDSPCSGG PIVSHSGPYI
241 PSSHSVSGGQ RPVVVVVDQH GSGAPGVVQG PPCSNGGLPG KPCPPITSVD KSYGGYEVVG
301 GSSDSYLVPG MTYSKGKIYP VGYFTKENPV KGSPGVPSFA AGPPISEGKY FSSNPIIPSQ
361 SAASSAIAFQ PVGTGGVQLC GGGSTGSKGP CSPSSSRVPS SSSISSSSGL PYHPCGSASQ
421 SPCSPPGTGS FSSSSSSQSS GKIILQPCGS KSSSSGHPCM SVSSLTLTGG PDGSPHPDPS
481 AGAKPCGSSS AGKIPCRSIR DILAQVKPLG PQLADPEVFL PQGELLNSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDSN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 664 nTPM
Expression across tissuesHPA
Tissue
- skin: 664 nTPM
- cervix: 7.5 nTPM
- vagina: 5.8 nTPM
- epididymis: 2.8 nTPM
- skeletal muscle: 0.7 nTPM
- salivary gland: 0.6 nTPM
Single-cell type
- cardiomyocytes: 2.9 nCPM
- endometrial luminal cells: 2.7 nCPM
- epicardial cells: 2.3 nCPM
- renal collecting duct principal cells: 1.3 nCPM
- endometrial glandular cells: 1.2 nCPM
- epididymal efferent duct absorptive cells: 0.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDSN.
Disease | AllUniProt
Conditions CDSN is implicated in, by any mechanism.
- Hypotrichosis 2 (HYPT2) MIM:146520
- Peeling skin syndrome 1 (PSS1) MIM:270300
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 165 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Peeling skin syndrome 1
- Hypotrichosis 2
- CDSN-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid fibril formation
- cell adhesion
- cell-cell adhesion
- corneocyte desquamation
- epidermis development
- keratinocyte differentiation
- skin morphogenesis
- negative regulation of cornification
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Corneodesmosin
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDSN as an antibody target. Whether an autoantibody or antibody against CDSN could matter depends on whether native CDSN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDSN is annotated as secreted, so native CDSN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CDSN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...